Introducing Bifidobacterium adolescentis iVS-1, the first clinically tested B. adolescentis strain available in the North American market.

Isolated from an elite athlete using our in vivo selection (iVS) platform, iVS-1 is bifidogenic, enhances gut barrier function, and improves lactose digestion.

A STRAIN WITH UNIQUE BENEFITS

iVS-1 produces high levels of GABA and folate and reduces gas formation from FODMAPs, fibers, and other carbohydrates.

ASSOCIATED WITH HEALTHY AGING

B. adolescentis is enriched in centenarians, suggesting it is the “missing microbe” for healthy aging and longevity.

COMMERCIALLY AVAILABLE

Before now, B. adolescentis was absent from products on the probiotic shelf. Now Synbiotic Health has made iVS-1 available for the supplement and food market.

We envision a better understanding of gut-dwelling microbial species and how they interact with food in the body to impact our health, enabling us to tailor the gut ecosystem and nutrition to each person using the best combination of bacterial strains and carbohydrates.”

“Our approach provides an ecological and evolutionary basis for the selection of strains for probiotic applications in different hosts.”

– Jens Walter, Synbiotic Health Scientific Co-Founder

Let’s have a conversation about your product innovation needs and how we can help.

Recent news

New paper shows how to predict prebiotic responders using metagenomics and machine learning

Although several prebiotic substrates have been consistently…

Tolerance and adaptation to dietary fiber linked to Bifidobacterium longum

Research from Synbiotic Health co-founder Prof. Jens Walter and…

Synbiotic Health Team to Attend Probiota 2024

The Synbiotic Health Team will be attending Probiota Americas…